Life-threatening emergency? Call 911
Member Services: (951) 791-1111
Enrollment Information: (951) 390-2840

Group B Strep Disease

NOTE: The medical information on this website is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. No provider-patient relationship is created by your use of this site. Always consult your own physician or qualified healthcare provider before making any health decisions — never disregard or delay professional medical advice because of something you read here. Read the full Medical Information Disclaimer HERE.

If you are experiencing a medical emergency, call 911 immediately.

At PromiseCare Medical Group in Hemet, California, healthcare providers emphasize the importance of screening for Group B strep disease in pregnant women. This bacterial infection, often asymptomatic, affects 10-30% of expectant mothers and can have severe consequences for newborns if left untreated. A routine swab test around 36-37 weeks of pregnancy can identify Group B strep, allowing for targeted prevention. Research and clinical experience at PromiseCare Medical Group have shown that administering antibiotics during labor can prevent up to 90% of infections in newborns. Understanding the risks and prevention strategies is crucial for expectant mothers to ensure the best possible outcomes for their babies.

Overview

The human body is home to trillions of microorganisms. For many women, one of these microorganisms is Group B strep, a common bacterium residing in the vagina or rectal area without triggering noticeable symptoms. Pregnant women should be aware of the risks associated with Group B streptococcus, also known as GBS.

Approximately 10-30% of pregnant women carry GBS, often without realizing it. A quick and painless swab typically performed around 36 weeks of pregnancy tests for GBS. The test results are usually available within 1-2 days.

If a pregnant woman tests positive, antibiotics will be administered during labor. Penicillin is the preferred antibiotic for this treatment, significantly reducing the risk of infection in newborns.

Untreated GBS infections can lead to severe and potentially life-threatening complications, including sepsis, pneumonia, and meningitis, in newborns within the first week of life. This condition is known as early-onset GBS disease.

Knowing GBS status is crucial in minimizing risks associated with this common bacterium. It allows pregnant women to take proactive steps to keep themselves and their babies safe.

Symptoms

Many people carrying Group B strep won’t exhibit noticeable symptoms, but when they do, the signs can be subtle yet alarming. Adults might experience fever, chills, fatigue, and chest pain, especially if they’re older or have underlying health conditions. These symptoms are rare, but it’s essential to take them seriously, as GBS infection can lead to serious illness.

New parents should monitor their newborns closely for signs of GBS infection. Within the first week of life, babies may exhibit fever, feeding difficulties, irritability, lethargy, or abnormal responsiveness.

In severe cases, GBS can cause sepsis, pneumonia, or meningitis, potentially leading to long-term neurological issues like cerebral palsy. Even after the initial week, parents should remain vigilant for late-onset symptoms, such as fever, irritability, and seizures, which can appear between 7 days and 3 months.

Medical attention should be sought immediately if any of these symptoms are noticed in the newborn or the parent. Prompt treatment is critical to mitigating severe outcomes and ensuring a healthy recovery from GBS infection.

Causes

Causes of Group B strep disease involve several risk factors that increase the likelihood of passing the bacteria to the baby during childbirth. Prolonged labor, fever during delivery, and urinary tract infections during pregnancy are factors that heighten the risk of transmission. Understanding these risk factors and potential complications is essential in preventing the spread of GBS and protecting the newborn’s health.

Risk factors

Carrying Group B strep during pregnancy can be a silent threat, as 10-30% of expectant mothers harbor the bacteria without showing any symptoms. Pregnant individuals should understand the risk factors associated with GBS transmission to their newborn.

The risk of passing GBS to the baby is higher if there is a history of GBS infections. If a previous child had a GBS infection, subsequent pregnancies are at increased risk of GBS-related complications. Preterm birth or prolonged ruptured membranes can increase the likelihood of GBS transmission during labor and delivery. A fever during labor can facilitate the transmission of GBS to the newborn. Additionally, a urinary tract infection caused by GBS during pregnancy can increase the risk of early-onset GBS disease in the newborn.

Administering antibiotics during labor can greatly reduce the risk of early-onset GBS disease in newborns. Testing positive for GBS typically results in a recommendation for antibiotics to minimize the risk of transmission. Understanding the risks and working closely with a healthcare provider is essential for a safe delivery.

Complications

When Group B strep gains a foothold in a newborn’s fragile system, it can set off a devastating chain reaction. The potential complications are worrying and include sepsis, pneumonia, and meningitis. Newborns are at a high risk of developing these life-threatening infections, with early-onset GBS disease occurring in approximately 1 in 300 to 1 in 500 live births.

GBS meningitis poses a significant risk of long-term damage to a baby’s neurological system. Infants who develop GBS meningitis may suffer from lifelong conditions like cerebral palsy and learning disabilities, with around 25% experiencing such outcomes.

Premature infants are especially vulnerable, with a mortality rate of about 5% even with treatment. Untreated GBS infections in pregnant individuals can lead to urinary tract infections, which increase the risk of preterm labor and premature rupture of membranes.

Adults with underlying conditions, such as diabetes, also face serious complications from GBS infections, including pneumonia, bacteremia, and toxic shock syndrome.

Diagnosis

Every pregnant woman approaches the 36-week mark with a mix of excitement and nervous anticipation, and for good reason—it’s around this time that testing for Group B strep typically takes place. This painless test involves a cotton swab from the vagina and rectum, and the results are usually available within 48 hours.

A positive test result for GBS means the bacteria are present, and re-testing isn’t necessary. The next steps will be discussed with a healthcare provider. Testing is a simple process, usually performed between 36-37 weeks of pregnancy. No re-testing is needed—a positive result means the bacteria are present throughout pregnancy. If GBS is detected in the urine, treatment with oral antibiotics will begin immediately, and intravenous antibiotics will be administered during labor. Treatment prevents most infections—administering antibiotics during labor can prevent up to 90% of GBS infections in newborns, providing reassurance.

Early detection and intervention are crucial in ensuring the best possible outcome for both mother and baby.

Treatment

Treating Group B strep is a crucial step in safeguarding the health of both mother and baby during late pregnancy. If a pregnant woman tests positive for GBS, treatment is recommended to greatly reduce the risk of transmission to the newborn. This typically involves receiving intravenous antibiotics during labor, with penicillin being the preferred choice. Receiving treatment at least four hours before delivery maximizes its effectiveness.

If GBS is detected in the urine during pregnancy, oral antibiotics are started right away, followed by intravenous treatment during labor. This two-step approach helps guarantee that the infection is fully cleared.

Even if treatment is received during labor, the newborn is still monitored for signs of GBS infection. If an infection does occur, the baby receives intravenous antibiotics to combat it.

With prompt and proper treatment, the risk of GBS transmission to the newborn can be reduced by approximately 90%. Taking proactive steps gives the baby the best possible start in life.

Medications

Medications play a crucial role in preventing the transmission of Group B strep to newborns. Antibiotics are effective in reducing the risk of GBS infections in babies. The preferred choice is penicillin G, but ampicillin is also an option. For individuals allergic to penicillin, clindamycin and vancomycin are effective alternatives, although sensitivity testing is necessary for clindamycin.

Penicillin G is the first-line antibiotic for treating GBS infections during labor. Ampicillin serves as an alternative to penicillin G for preventing GBS transmission. Clindamycin is an option for those allergic to penicillin, but sensitivity testing is necessary. Vancomycin is another alternative for penicillin-allergic individuals, often used during labor.

Receiving these medications at least four hours before delivery is crucial to maximize their effectiveness. This can prevent up to 90% of GBS infections in newborns. Understanding medication options can help individuals feel more confident and in control in keeping their baby safe from Group B strep.

Surgery

During surgery, patients are already vulnerable, and the last thing they want is a Group B strep infection complicating their recovery. Individuals with underlying conditions like diabetes or obesity are at increased risk of developing a postoperative GBS infection. Symptoms such as fever, chills, or localized pain at the surgical site require immediate medical attention.

Antibiotic prophylaxis may be recommended for patients known to be GBS positive, particularly for procedures involving the gastrointestinal tract or urogenital systems, to minimize the risk of GBS infections. However, some infections may not respond to antibiotics alone. In such cases, surgical intervention may be necessary to resolve skin and soft tissue infections.

Monitoring for antibiotic resistance is also essential, as high rates of clindamycin and erythromycin resistance have been reported in GBS infections.

Healthcare teams at PromiseCare work closely with patients to manage any infections that may arise after surgery, prioritizing their safety and recovery. By taking proactive measures, patients can reduce their risk of GBS infections and have a smoother recovery from surgery.

Lifestyle and home remedies

Many people look for ways to minimize their risk of developing Group B strep infections, especially during pregnancy. By maintaining good overall health, individuals can support a stronger immune system and lower their risk of complications.

Practice good hygiene by washing hands regularly, especially after using the bathroom, and keeping the genital area clean. Stay healthy through a balanced diet by eating nutrient-rich foods, such as fruits, vegetables, and whole grains, which support the immune system. Stay hydrated and manage stress by drinking plenty of water throughout the day and trying stress-reducing techniques like meditation, deep breathing, or prenatal yoga. Attend regular prenatal visits to allow for monitoring of Group B strep and other potential health concerns, ensuring timely intervention if needed.

Avoiding smoking and limiting alcohol consumption can enhance immune function and reduce the risk of adverse outcomes related to Group B strep infections. Maintaining overall health, including regular exercise, can also help minimize risks. Regular prenatal visits play an essential role in keeping pregnant individuals and their babies safe and healthy throughout pregnancy.

Preparing for your appointment

To prepare for your appointment, gather relevant medical history to share with your healthcare provider, including any previous pregnancies, infections, or complications related to Group B strep. Write down your questions and concerns about GBS, such as the risks to your baby, the need for testing, and potential treatment options if you test positive.

Be prepared to discuss any symptoms you’ve experienced, like fever or unusual discharge, as these can inform your healthcare provider’s assessment of your GBS risk. Mention any family history of infections or complications that may affect your pregnancy and GBS screening.

If you test positive for GBS, discuss the logistics of care during labor, including the administration of antibiotics and any monitoring procedures for your baby after delivery. Being open and informed can help minimize the risk of Group B strep complications and guarantee a healthy outcome for you and your baby.

What you can do

Taking an active role in managing Group B strep during pregnancy can be incredibly empowering, especially when it comes to protecting the baby’s health. As one prepares for motherhood, it’s crucial to stay informed about the risks associated with GBS and the steps that can be taken to minimize them.

To guarantee a healthy pregnancy and delivery, women should get tested for GBS between 36-37 weeks of pregnancy and discuss the importance of GBS screening with a healthcare provider. Understanding the risks and benefits of intravenous antibiotics is essential—if the test is positive for GBS, receiving intravenous antibiotics during labor greatly reduces the risk of transmission to the newborn. Monitor for signs of infection by keeping an eye out for any unusual symptoms or fever and reporting them to a healthcare provider immediately. Stay informed about GBS infections in newborns by educating yourself on the symptoms of GBS infections in newborns and seeking immediate medical attention if they occur.

When to see a doctor

Navigating pregnancy and childbirth with the added concern of Group B strep disease requires understanding what to expect from your healthcare provider. You’ll typically be screened for GBS between 36 and 37 weeks of pregnancy, and a treatment plan will be developed to minimize risks if you test positive.

What to expect from your doctor

Prompt medical attention is essential if you’re pregnant and start experiencing symptoms like fever, chills, or unusual vaginal discharge, as these could indicate a Group B Strep infection or other complications. A healthcare provider will assess your condition, considering factors like your medical history and any previous experiences with GBS in past pregnancies.

When discussing GBS, expect GBS testing recommendations typically between 36-37 weeks of pregnancy, when a healthcare provider will suggest testing for GBS to gauge your risk and devise an appropriate management plan. Your healthcare provider will conduct an assessment of infection risk—if you have a history of GBS, experience prolonged rupture of membranes, or fever during labor, intrapartum antibiotic prophylaxis may be recommended to minimize the risk of infection. After delivery, expect newborn monitoring for signs of infection within the first three months, such as difficulty breathing or feeding issues. Throughout the process, maintain open communication—any questions or concerns about GBS will be addressed, devising a comprehensive care plan that prioritizes your health and the well-being of your baby.

Not Sure What Your Symptoms Mean?

A PromiseCare Provider can evaluate your symptoms and recommend the right treatment plan.

Explore Health Topics

You Don’t Have to Figure This Out Alone

Connect with a PromiseCare provider who can help you understand your condition and guide your next steps.
Clarity you can actually use.